APEX1 and myelodysplastic syndrome: Since both drugs act on the DNA damage response, γH2AX foci (as a readout for DNA damage) were analyzed for their potential correlation with the cytotoxic efficacy of talazoparib and APE1 inhibitor III in MDS/CMML and AML cells.